Issue 112 • November 2021

Optimising real-world data

Can pharma stop us from ageing?

Regulating a global generics industry

In association with

The ethics of vaccine boosters

As several nations prepare to roll out Covid-19 vaccine booster programmes, less wealthy countries are still struggling to access a first dose

In association with

02/24/2024 06:49:09
  • Home | Unpacking innovation in biologics 
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Verder Company Insight
  • Verder
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Controlant Company Insight
  • Controlant
  • Datwyler
  • Baxter
  • Comment
  • Novel therapies will drive Cushing’s syndrome market growth
  • Interim analysis backs Keytruda use in first-line cervical cancer therapy
  • Unmet needs and opportunities for axillary hyperhidrosis
  • Pfeiffer Vacuum
  • HOF Sonderanlagenbau
  • Avery Dennison Company Insight
  • Avery Dennison
  • In Depth
  • The reality of optimising real-world data
  • The ethics of vaccine boosters
  • Forever young: can science cure ageing?
  • Predicting the placebo response
  • US regulators struggle to keep up with a global market
  • BCG: the history and modern-day uses of the tuberculosis vaccine
  • BEA Technologies
  • Myonex
  • Contract Pharmaceuticals Limited Canada
  • Single Use Support
  • Skyepharma
  • In Data
  • Cloud hiring efforts
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
10/21/2021 00:00:00